Patents Assigned to Contera Pharma A/S
  • Pulsatile drug delivery system for treating morning akinesia
    Patent number: 11975104
    Abstract: Provided herewith is a pharmaceutical composition comprising, separately or together, a pulsatile release component comprising levodopa and a DOPA decarboxylase inhibitor for the management of OFF-time episodes in patients with Parkinson's disease.
    Type: Grant
    Filed: July 11, 2017
    Date of Patent: May 7, 2024
    Assignee: Contera Pharma A/S
    Inventors: John Bondo Hansen, Mikael Søndergård Thomsen, Ann Vivian Fullerton, Bent Højgaard, Peter Gudmund Nielsen
  • Combinations of serotonin receptor agonists for treatment of movement disorders
    Patent number: 10632116
    Abstract: The present invention relates to the use of 5-HT1 agonists in pharmaceutical compositions, compounds and methods for treatment of movement disorders related to neurological dysfunctions. The invention is particularly relevant for treatment of patients suffering from tardive dyskinesia, Parkinson's disease and associated disorders thereof. Kits of parts comprising the 5-HT1 agonist compounds or pharmaceutical compositions according to the present invention, as well as methods of preparation are also provided by the present invention.
    Type: Grant
    Filed: November 10, 2015
    Date of Patent: April 28, 2020
    Assignee: Contera Pharma A/S
    Inventors: John Bondo Hansen, Mikael S. Thomsen